Clinical Trial

A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study will examine the potential efficacy and safety of Rett-T for core motor deficits of Rett syndrome, and will explore biological markers of safety and treatment response.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-11-30 -> 2027-12-30 2026-07-28
minor Completion pushed: 2026-11-30 -> 2027-12-30 2026-07-28
Trial Details
NCT Number NCT04041713
Lead Sponsor Holland Bloorview Kids Rehabilitation Hospital
Collaborators: Ontario Brain Institute, Unity Health Toronto
Conditions Rett Syndrome
Enrollment 35 participants
Start Date 2026-08-17
Primary Completion 2027-12-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-27